BPC
TNDM icon

Bryce Point Capital’s Tandem Diabetes Care TNDM Stock Holding History

Bryce Point Capital’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$513K Buy
+42,258
New +$572K 0.63% 97

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
FGP
Freestone Grove Partners San Francisco, California $14.2B AUM 24.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bryce Point Capital's TNDM Position: Q3 2025 in Review

Bryce Point Capital opened a new position in Tandem Diabetes Care (TNDM) in Q3 2025: 42,258 shares worth $513K. The stake represents 0.63% of the portfolio and ranks #97 among its holdings.

255 funds tracked by Wall St. Rank hold TNDM as of Q3 2025.

  • Bryce Point Capital held 42,258 shares of Tandem Diabetes Care worth $513K as of Q3 2025.
  • Tandem Diabetes Care was a new Bryce Point Capital position in Q3 2025.
  • Tandem Diabetes Care made up 0.63% of Bryce Point Capital's portfolio in Q3 2025, its #97 holding.
  • 255 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2025.

Based on Bryce Point Capital's 13F filing for Q3 2025, filed 6 Nov 2025.